ENSYSCE BIOSCIENCES INC (ENSC)

Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product

Which stocks are moving on Friday?

Here are the top movers in Friday's session, showcasing the stocks with significant price changes.

Let's take a look at the stocks that are in motion in today's session.

Which stocks are experiencing notable movement on Friday?

The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.

Friday's session: gap up and gap down stocks

Ensysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR

Ensysce Biosciences Announces 1-for-15 Reverse Stock Split

Ensysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR Trial

Ensysce Biosciences Reports Third Quarter 2024 Financial Results

Ensysce Biosciences Receives Positive Nasdaq Listing Determination

Ensysce Biosciences Announces Leadership Team’s Participation in the Annual Pain Therapeutics Summit

Ensysce Biosciences Provides Shareholder Update, Responds to Recent Shareholder Inquiries

Ensysce Biosciences Receives Notice from Nasdaq

Ensysce Biosciences Presenting at Upcoming Meetings

Ensysce Biosciences Submits Phase 3 Protocol to the FDA

Ensysce Biosciences Posts Video Updates from the IASP World Congress on Pain 2024